Clinical Trial: A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: A Multicentre Prospective Study in Patients Undergoing Ventral Hernia Repair by Open Approach With Intraperitoneal Positioning Using Parietex™ Composite Ventral Patc

Brief Summary: The objective of this study is to assess the recurrence rate following the use of PARIETEX™ Composite Ventral Patch in primary ventral hernia repair by open approach with intra‐peritoneal positioning.

Detailed Summary:

Prospective, multicenter, multinational non‐comparative study.

Primary Endpoint: Primary hernia recurrence* rate at 24 month follow‐up. The evaluation of hernia recurrence will be performed during a physical examination and by ultrasonography.

Secondary Endpoints: Primary hernia recurrence* rate at 1, 6 and 12 month follow‐up. The evaluation of hernia recurrence will be performed during a physical examination and confirmed by ultrasonography.

(*Recurrence is defined as a clinically manifested bulge or a protrusion exacerbated by a Valsalva maneuver.)

Safety Parameters:

Deep and superficial infection (A Surgical Site Infection (SSI) will be defined in the study according to the Centers for Disease Control and Prevention (CDC) criteria for diagnosis of SSI).

Pain / Chronic pain Other post‐operative complications (complications related to visceral adhesions, Ileus, seroma, hematoma...) Analgesics consumption Risk factors (severity and treatment) Efficacy Parameters: Recurrence of primary ventral hernia Operative time Time of the mesh positioning Length of Hospital Stay Ease of use (Mesh handling and manipulability, comfort of use …) Return to daily activities/ work Patient satisfaction Patient comfort (Carolina's™ Comfort scale (CCS) - QoL questionnaire)

Visit Schedule:

Baseline visit (Preoperative) & Operative/Discharge visit

Post-Op:

Phone call Day 10

The evaluation of hernia recurrence will be performed during a physical examination and by ultrasonography.



Original Primary Outcome: Same as current

Current Secondary Outcome: Recurrence rate at 1, 6 and 12 month follow‐up [ Time Frame: 1, 6 and 12 month follow‐up. ]

The evaluation of hernia recurrence will be performed during a physical examination and confirmed by ultrasonography.


Original Secondary Outcome: Same as current

Information By: Medtronic - MITG

Dates:
Date Received: May 2, 2013
Date Started: May 2013
Date Completion: April 2017
Last Updated: March 21, 2017
Last Verified: March 2017